Johnson & Johnson (NYSE:JNJ) is among the most profitable healthcare stocks to buy. On January 22, TD Cowen lifted the price ...
Johnson & Johnson (NYSE:JNJ) received FDA approval for DARZALEX FASPRO in combination with D-VRd. The regimen is approved for ...
Zacks Investment Research on MSN
Johnson & Johnson (JNJ) reports next week: Wall Street expects earnings growth
Wall Street expects a year-over-year increase in earnings on higher revenues when Johnson & Johnson (JNJ) reports results for the quarter ended December 2025. While this widely-known consensus outlook ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results